Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Immunomodulatory Effects of Canine Adipose Tissue Mesenchymal Stem Cell-Derived Extracellular Vesicles on Stimulated CD4 + T Cells Isolated from Peripheral Blood Mononuclear Cells.

Teshima T., Yuchi Y., Suzuki R., Matsumoto H., Koyama H.

Animal Study on Chronic Inflammation, Immune Modulation, published in J Immunol Res (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Immunol Res (2021)
Country
Egypt
Reported sample size
—
Source database
PubMed
PMID
34447855
PMCID
PMC8384509
DOI
10.1155/2021/2993043
Citations
14

Abstract (original English)

Adipose tissue-derived mesenchymal stem cells (ADSCs) have anti-inflammatory and immunomodulatory characteristics. Many studies have suggested that the immunomodulation of ADSCs is largely mediated by secreted paracrine factors. Various factors are secreted from ADSCs, among which extracellular vesicles are considered to play a major role in the communication between ADSCs and target cells. Several studies have reported the function of canine ADSC-derived extracellular vesicles (cADSC-EVs), but few studies have reported the immunomodulatory effects of cADSC-EVs on immune cells. The purpose of this study was to investigate the effects of cADSC-EVs on in vitro -stimulated CD4 + T cells isolated from peripheral blood mononuclear cells (PBMCs). cADSC-EVs were isolated from cADSCs under naive conditions or primed conditions by tumor necrosis factor- α (TNF α ) and interferon- γ (IFN γ ). The expression levels of several microRNAs in cADSC-EVs were altered by priming with TNF α and IFN γ . Culturing PBMCs stimulated with concanavalin A in the presence of naive or primed cADSC-EVs inhibited the differentiation of PBMCs and CD4 + T cells and promoted apoptosis of PBMCs. CD4 + , CD8 + , and CD4 + CD8 + T cells were decreased, while CD3 + CD4 - CD8 - T cells were increased. T helper (Th) 1, Th2, Th17, and regulatory T (Treg) cells were analyzed by flow cytometry. cADSC-EVs inhibited the

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsCD4-Positive T-LymphocytesCells, CulturedCoculture TechniquesDogsExtracellular VesiclesImmunosuppression TherapyInterferon-gammaMesenchymal Stem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research